Evidence map›Paper›PMID 42432245›Full record

ArticleNature genetics2026

The PRECISE European initiative for cancer-vulnerability mapping and prediction.

Francesco Iorio, Mathew J Garnett, Pedro Beltrao, Maximilian Billmann, Larissa Bless, Christoph Bock, Michael Boutros, Alejandra Bruna, Piero Carninci, Giovanni Ciriello and 26 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Francesco Iorio *Human Technopole, Milan, Italy. francesco.iorio@fht.org.ORCID http://orcid.org/0000-0001-7063-8913
Mathew J Garnett *Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. mg12@sanger.ac.uk.ORCID http://orcid.org/0000-0002-2618-4237
Pedro BeltraoInstitute of Molecular Systems Biology, ETH Zürich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-2724-7703
Maximilian BillmannInstitute of Human Genetics, University of Bonn, School of Medicine and University Hospital Bonn, Bonn, Germany.ORCID http://orcid.org/0000-0002-6556-9594
Larissa BlessDublin City University, Dublin, Ireland.ORCID http://orcid.org/0000-0002-9904-3953
Christoph BockCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID http://orcid.org/0000-0001-6091-3088
Michael BoutrosInstitute of Human Genetics and German Cancer Research Center (DKFZ), Heidelberg University, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-9458-817X
Alejandra BrunaCentre for Evolution and Cancer, Division of Cancer Biology, The Institute of Cancer Research, Sutton, UK.ORCID http://orcid.org/0000-0003-1214-9665
Piero CarninciHuman Technopole, Milan, Italy.ORCID http://orcid.org/0000-0001-7202-7243
Giovanni CirielloDepartment of Computational Biology, University of Lausanne, Lausanne, Switzerland.ORCID http://orcid.org/0000-0003-2021-8683
Isidro Cortés-CirianoWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.ORCID http://orcid.org/0000-0002-2036-494X
Giuseppina D'AlessandroIFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.
Roberta EspositoUrology Research Laboratory, Department for BioMedical Research, University of Bern, Bern, Switzerland.
Stefania FalettiHuman Technopole, Milan, Italy.ORCID http://orcid.org/0000-0003-2489-1795
Emanuel GonçalvesInstituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal.ORCID http://orcid.org/0000-0002-9967-5205
Syed HaiderThe Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.ORCID http://orcid.org/0000-0001-6685-5480
Nereo KalebicHuman Technopole, Milan, Italy.
Manuel KaulichInstitute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt, Germany.ORCID http://orcid.org/0000-0002-9528-8822
Giuseppe LeuzziIFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.
Nuria Lopez-BigasInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID http://orcid.org/0000-0003-4925-8988
Christopher J LordThe Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.ORCID http://orcid.org/0000-0002-3226-0515
Evangelia PetsalakiEuropean Molecular Biology Laboratory-European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, UK.
Stephen PettittThe Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.ORCID http://orcid.org/0000-0003-3313-3857
Ludovica ProiettiHuman Technopole, Milan, Italy.
Roland RadInstitute of Molecular Oncology and Functional Genomics, School of Medicine, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-6849-9659
Nevenka RadicHuman Technopole, Milan, Italy.ORCID http://orcid.org/0000-0001-5551-3223
Colm J RyanConway Institute, University College Dublin, Dublin, Ireland.ORCID http://orcid.org/0000-0003-2750-9854
Jonathan L Schmid-BurgkInstitute of Clinical Chemistry and Clinical Pharmacology, University and University Hospital Bonn, Bonn, Germany.
Sumana SharmaRadcliffe Department of Medicine, University of Oxford, Oxford, UK.
Andrea SottorivaHuman Technopole, Milan, Italy.ORCID http://orcid.org/0000-0001-6709-9533
Christopher TapeCancer Institute, University College London, London, UK.ORCID http://orcid.org/0000-0003-4712-2737
Livio TrusolinoCandiolo Cancer Institute FPO IRCCS, Candiolo, Torino, Italy.ORCID http://orcid.org/0000-0002-6379-3365
Jolanda van LeeuwenCenter for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.ORCID http://orcid.org/0000-0003-3991-518X
David WalterCancer Research Horizons, Cambridge, UK.ORCID http://orcid.org/0000-0003-4363-0339
Lodewyk WesselsThe Netherlands Cancer Institute, Amsterdam, the Netherlands.ORCID http://orcid.org/0000-0002-1656-6995
PRECISE consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42432245

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.